Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Legend Biotech
Legend Biotech
Despite early death concerns, FDA advisers back J&J and Legend's Carvykti and BMS' Abecma for earlier myeloma
Fierce Pharma
Sun, 03/17/24 - 09:30 pm
JNJ
Legend Biotech
CAR-T
FDA
Carvykti
Abecma
FDA Adcomm to Tackle Complexity of CAR-T for Multiple Myeloma
BioSpace
Mon, 03/11/24 - 11:53 am
CAR-T
Multiple Myeloma
FDA
Bristol Myers Squibb
2seventy bio
Abecma
JNJ
Legend Biotech
Carvykti
J&J, Legend to Face Adcomm for Carvykti’s Push as Earlier Line MM Treatment
BioSpace
Wed, 01/24/24 - 10:40 am
JNJ
Legend Biotech
FDA
Carvykti
Multiple Myeloma
Novartis pays Legend $100M upfront to give solid tumor CAR-T the T-Charge treatment
Fierce Biotech
Mon, 11/13/23 - 11:55 am
Novartis
Legend Biotech
CAR-T
T-Charge
solid tumors
Legend Biotech to Showcase Leadership in Multiple Myeloma Treatment at the ASH 2023 Annual Meeting
BioSpace
Thu, 11/2/23 - 11:36 am
Legend Biotech
Multiple Myeloma
cilta-cel
ASH 2023
After launch limitations, Johnson & Johnson exec touts manufacturing progress on CAR-T drug Carvykti
Fierce Pharma
Wed, 10/18/23 - 07:44 pm
JNJ
Legend Biotech
Multiple Myeloma
CAR-T
Carvykti
cell therapy
3 Biotech Stocks Poised to Beat Q2 Earnings Estimates
Yahoo/Zacks.com
Mon, 08/14/23 - 11:15 am
earnings
Legend Biotech
Kodiak Sciences
Galera Therapeutics
J&J sees trial data supporting earlier CAR-T use in multiple myeloma
BioPharma Dive
Mon, 06/5/23 - 10:12 am
ASCO 2023
JNJ
Legend Biotech
Carvykti
CAR-T
Multiple Myeloma
J&J, Legend's Carvykti cut risk of progression or death by whopping 74% in earlier myeloma, leaked abstract shows
Fierce Pharma
Wed, 04/19/23 - 11:24 am
CAR-T
Bristol Myers Squibb
JNJ
Legend Biotech
AACR
Multiple Myeloma
Carvykti
Abecma
Johnson & Johnson shelves Carvykti's UK launch amid manufacturing shortfalls
Fierce Pharma
Wed, 03/15/23 - 09:27 pm
JNJ
Legend Biotech
CAR-T
Carvykti
J&J, Legend’s cancer cell therapy has early success in key clinical trial
BioPharma Dive
Mon, 01/30/23 - 10:27 am
JNJ
Legend Biotech
Carvykti
Multiple Myeloma
clinical trials
cell therapy
Sales of J&J, Legend cell therapy plateau amid production challenges
BioPharma Dive
Wed, 01/25/23 - 10:57 pm
JNJ
Legend Biotech
gene therapy
Carvykti
Multiple Myeloma
Gilead lands new cell therapy for Kite in $225M Arcellx deal
Fierce Biotech
Fri, 12/9/22 - 10:37 am
Gilead Sciences
Kite Pharma
Arcellx
clinical trials
Multiple Myeloma
cell therapy
JNJ
Legend Biotech
FDA approves Legend Biotech’s IND application for lung cancer therapy trial
Clinical Trials Arena
Tue, 11/22/22 - 10:58 am
FDA
Legend Biotech
LB2102
small cell lung cancer
J&J partner Legend Biotech looks to raise $250M amid Carvykti rollout, global expansion
Fierce Pharma
Wed, 07/27/22 - 10:28 am
JNJ
Legend Biotech
Carvykti
CAR-T
Legend scraps early-stage CAR-T for lymphoma 6 weeks after clinical hold lifted
Fierce Biotech
Fri, 07/8/22 - 10:32 am
Legend Biotech
CAR-T
cell therapy
clinical trials
lymphoma
LB1901
ASCO: J&J, Legend reveal more CAR-T data and a look at Carvykti for earlier myeloma in a difficult population
Fierce Pharma
Fri, 05/27/22 - 10:33 am
ASCO 2022
JNBJ
Legend Biotech
Carvykti
CAR-T
Multiple Myeloma
Legend Biotech Achieves Milestone Under Collaboration Agreement with Janssen Biotech, Inc. for BCMA CAR-T
BioSpace
Thu, 04/21/22 - 10:57 am
Legend Biotech
Janssen
Carvykti
cilta-cel
CAR-T
2 Biotechs With Recent FDA Approvals to Hold for the Next Decade
Motley Fool
Wed, 04/6/22 - 12:24 pm
Legend Biotech
CAR-T
Immunocore
TCR immunotherapy
J&J, Legend cell therapy approved by FDA for multiple myeloma
BioPharma Dive
Mon, 02/28/22 - 11:44 pm
JNJ
Legend Biotech
FDA
Multiple Myeloma
Carvykti
CAR-T
Pages
1
2
next ›
last »